HEALTH● LOWJul 31 · Jul 31, 2026, 2:45 PM
Handa Oncology Receives FDA Tentative Approval for OMCAZIO ( cabozantinib ) Capsules
tennesseedaily.com · United States
Handa Oncology has received tentative FDA approval for its OMCAZIO (cabozantinib) capsules. This marks a significant regulatory milestone for a new oncology treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
POLITICS1h agoIranian president blames United States for failure of interim peace dealAfricanews [en]WORLD14h agoF1 United States GP: race schedule, how and where to watch Formula 1ClarínPOLITICS16h agoCountdown to the United States elections: Donald Trump and Melania voted earlyClarínPOLITICS20h agoALÇUFROM : What the United States gets wrong about France student protests - The Cavalier Daily - University of Virginia Student Newspapercavalierdaily.com · United States
More in Health
HEALTHBREAKING21m agoJUST IN: Ebola: Nigeria identifies 53 contacts linked to confirmed casePremium TimesHEALTH26m agoEbola: Uganda Announces 21-Day Quarantine For Returnees From DR CongoChannels TVHEALTH49m agoLluís Benítez, veterinary oncologist: “It is known, statistically, that cancer is the cause of death for half of dogs over 10 years old”ClarínHEALTH57m agoConcerns about quality of health care, unemployment, as RMPs in Keralam cross one-lakh markThe Hindu